Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (431-440 of 566) with videos related to

Pageof 57
Sort By:
Journal of Affective Disorders|December 23, 2018
Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failureAhmed T Ahmed, Joanna M Biernacka, Gregory Jenkins, et al.
The Journal of Clinical Psychiatry|March 29, 2006
Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D reportMadhukar H Trivedi, A John Rush, Stephen R Wisniewski, et al.
Nature Biotechnology|March 27, 2012
A proteomics approach for the identification and cloning of monoclonal antibodies from serumWan Cheung Cheung, Sean A Beausoleil, Xiaowu Zhang, et al.
Journal of Psychiatric Practice|October 4, 2008
An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorderAndrew F Leuchter, Ira M Lesser, Madhukar H Trivedi, et al.
Archives of General Psychiatry|October 6, 2005
Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenonTrisha Suppes, Jim Mintz, Susan L McElroy, et al.
The Journal of Clinical Psychiatry|July 8, 2011
Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal riskMadhukar H Trivedi, Stephen R Wisniewski, David W Morris, et al.
Clinical Trials (London, England)|November 11, 2005
Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) projectStephen R Wisniewski, Heather Eng, Leslie Meloro, et al.
Frontiers in Neuroscience|October 2, 2019
Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT TreatmentSudeepa Bhattacharyya, Boadie W Dunlop, Siamak Mahmoudiandehkordi, et al.
Journal of Psychiatric Research|October 26, 2005
Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trialSteven D Hollon, Richard C Shelton, Stephen Wisniewski, et al.
The American Journal of Psychiatry|September 28, 2007
Effect of age at onset on the course of major depressive disorderSidney Zisook, Ira Lesser, Jonathan W Stewart, et al.
Pageof 57

Showing results (431-440 of 566) with videos related to

Sort By:
Pageof 57
Journal of Affective Disorders|December 23, 2018
Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failureAhmed T Ahmed, Joanna M Biernacka, Gregory Jenkins, et al.
The Journal of Clinical Psychiatry|March 29, 2006
Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D reportMadhukar H Trivedi, A John Rush, Stephen R Wisniewski, et al.
Nature Biotechnology|March 27, 2012
A proteomics approach for the identification and cloning of monoclonal antibodies from serumWan Cheung Cheung, Sean A Beausoleil, Xiaowu Zhang, et al.
Journal of Psychiatric Practice|October 4, 2008
An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorderAndrew F Leuchter, Ira M Lesser, Madhukar H Trivedi, et al.
Archives of General Psychiatry|October 6, 2005
Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenonTrisha Suppes, Jim Mintz, Susan L McElroy, et al.
The Journal of Clinical Psychiatry|July 8, 2011
Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal riskMadhukar H Trivedi, Stephen R Wisniewski, David W Morris, et al.
Clinical Trials (London, England)|November 11, 2005
Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) projectStephen R Wisniewski, Heather Eng, Leslie Meloro, et al.
Frontiers in Neuroscience|October 2, 2019
Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT TreatmentSudeepa Bhattacharyya, Boadie W Dunlop, Siamak Mahmoudiandehkordi, et al.
Journal of Psychiatric Research|October 26, 2005
Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trialSteven D Hollon, Richard C Shelton, Stephen Wisniewski, et al.
The American Journal of Psychiatry|September 28, 2007
Effect of age at onset on the course of major depressive disorderSidney Zisook, Ira Lesser, Jonathan W Stewart, et al.
Pageof 57